Dithiocarbamates have emerged as potent carbonic anhydrase (CA) inhibitors in recent years. Given that CAs are important players in cellular metabolism, the objective of this work was to exploit the CA-inhibitory property of dithiocarbamates as a chemotherapeutic weapon against the Leishmania parasite. We report here strong antileishmanial activity of three hitherto unexplored metal dithiocarbamates, maneb, zineb, and propineb. They inhibited CA activity in Leishmania major promastigotes at submicromolar concentrations and resulted in a dose-dependent inhibition of parasite growth. Treatment with maneb, zineb, and propineb caused morphological deformities of the parasite and Leishmania cell death with 50% lethal dose (LD 50 ) values of 0.56 M, 0.61 M, and 0.27 M, respectively. These compounds were even more effective against parasites growing in acidic medium, in which their LD 50 values were severalfold lower. Intracellular acidosis leading to apoptotic and necrotic death of L. major promastigotes was found to be the basis of their leishmanicidal activity. Maneb, zineb, and propineb also efficiently reduced the intracellular parasite burden, suggesting that amastigote forms of the parasite are also susceptible to these metal dithiocarbamates. Interestingly, mammalian cells were unaffected by these compounds even at concentrations which are severalfold higher than their antileishmanial LD 50 s). Our data thus establish maneb, zineb, and propineb as a new class of antileishmanial compounds having broad therapeutic indices.
L
eishmaniasis is a vector-borne disease caused by the protozoan parasite of the genus Leishmania. The disease is manifested in various clinical forms, ranging from self-healing skin ulcers to fatal infection of the visceral organs. With an estimated 1.3 million new cases and more than 20,000 deaths every year, leishmaniasis continues to be a threat to a huge population living in tropical and subtropical countries (1) .
To date, there is no antileishmanial vaccine for clinical use (2) . Treatment options are also few. After several decades of successful use against visceral leishmaniasis, the pentavalent antimonials have become almost obsolete because of resistance developed against these drugs (3) . This has led to the emergence of a second line of defense, including amphotericin B, paromomycin, and miltefosine (4) . However, severe side effects, cases of disease relapse after an initial cure, and increasing signs of resistance have limited their efficacy (5-7). The liposomal formulation of amphotericin B (AmBisome) is by far the most effective treatment for leishmaniasis, having minimal side effects (8) . Despite the effectiveness of AmBisome, its cost is a major point of concern, especially since this disease is prevalent in poorer sections of communities. Novel therapies against all forms of leishmaniasis are therefore urgently needed.
Carbonic anhydrases (CAs) are a family of metalloenzymes that catalyze reversible hydration of CO 2 . By catalyzing this simple reaction, they play vital roles in a wide variety of physiological processes ranging from ion transport and intracellular pH maintenance to the metabolic pathways of fatty acid biosynthesis, gluconeogenesis, and ureagenesis (9) . Although mammalian CAs have been extensively studied, much less is known about the function of CAs in microorganisms. There are several recent studies confirming the presence of CAs in bacteria (e.g., Mycobacterium tuberculosis and Helicobacter pylori), fungi (e.g., Cryptococcus neoformans and Saccharomyces cerevisiae), and protozoa (e.g., Plasmodium falciparum and Trypanosoma cruzi) (10) (11) (12) (13) (14) (15) . Since most of these microbes are dreaded pathogens, the idea of using CA inhibitors to restrict their growth has gained clinical significance (16) . Indeed, CA inhibitors were shown to inhibit in vitro growth of bacterial pathogens like H. pylori and Brucella suis (11, 17) . These promising results suggested that CAs can be exploited as antibacterial drug targets to circumvent the problem of resistance against classical antibiotics (18) .
Analysis of the Leishmania major genome sequence (as well as the genomes of other species of Leishmania) predicted the presence of two putative CAs (referred to here as LmCA1 and LmCA2, or LmCAs). Our results validated the constitutive expression of these two CA transcripts in L. major promastigotes. We also detected considerable CA activity in Leishmania cell lysates, thereby confirming the presence of functional CA in L. major. One of these LmCAs is a ␤-CA, which has recently been cloned from Leishmania chagasi and was shown to be inhibited by sulfonamides and thiol CA inhibitors. In fact, some of the heterocyclic thiols also inhibited in vitro growth of L. chagasi and Leishmania amazonensis promastigotes, albeit at a high concentration (MIC of ϳ256 M) (19) . These findings suggested that LmCAs may be exploited as antileishmanial drug targets.
Dithiocarbamates and their metal complexes have long been used as agricultural fungicides (20) . However, their molecular targets remained elusive until recently. The latest reports have established dithiocarbamates as a general class of CA inhibitors. They form coordinate with the active-site zinc ion of CA and inhibit the enzyme at submicromolar concentrations (21, 22) . Dithiocarbamates were shown to inhibit CAs from a number of pathogenic microorganisms such as M. tuberculosis, Legionella pneumophila, and C. neoformans (23) (24) (25) . Although dithiocarbamates inhibit both ␣-and ␤-CAs, they were found to be better inhibitors for ␤-CAs than other well-known CA inhibitors, such as sulfonamides and thiols (19, 25) . These in vitro CA inhibition studies encouraged us to explore the possibility of exploiting dithiocarbamates as a chemotherapeutic weapon against Leishmania parasites.
Three metal dithiocarbamate complexes, maneb, zineb, and propineb, were selected for this study after confirmation that they are efficient inhibitors of CA activity in Leishmania cells. In this report, we provide the first evidence of the antileishmanial activity of these metal dithiocarbamates. The ability of these compounds to target Leishmania promastigotes and amastigotes along with their broad therapeutic indices makes them promising candidates for drug development against leishmaniasis.
MATERIALS AND METHODS
Unless otherwise mentioned, all reagents, including the metal dithiocarbamates, were purchased from Sigma-Aldrich (St. Louis, MO).
Parasite and mammalian cell culture. Promastigotes of L. major (strain 5ASKH, kindly provided by Subrata Adak of IICB, Kolkata, India) were grown at 26°C in M199 medium (Gibco) supplemented with 15% fetal bovine serum (Gibco), 23.5 mM HEPES, 0.2 mM adenine, 150 g/ml folic acid, 10 g/ml hemin, 120 U/ml penicillin, 120 g/ml streptomycin, and 60 g/ml gentamicin. Unless otherwise mentioned, the pH of the medium was adjusted to 7.2. J774A.1 (murine macrophage cell line from the National Centre for Cell Science, Pune, India) and NIH 3T3 (murine fibroblast cell line from American Type Culture Collection) cells were grown in Dulbecco's modified Eagle's medium (Gibco) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 10% heat-inactivated fetal bovine albumin (Gibco) at 37°C in a humidified atmosphere containing 5% CO 2 .
RNA isolation and RT-PCR. Total RNA was isolated from L. major promastigotes using TRIzol reagent (Invitrogen) followed by DNase I (Invitrogen) digestion to remove DNA contaminants. cDNA was synthesized from 2 g of total RNA using an oligo(dT) primer and Moloney murine leukemia virus (MMLV) reverse transcriptase (RT) (Epicentre). The CA transcripts of L. major were amplified using gene-specific primers: LmCA1F, 5=-GCGCGAATTCATGTCGCTGTGCAGCTG-3=; LmCA1R, 5=-GCGCGAATTCCTACAGCTGCCCGTAGC-3=; LmCA2F, 5=-GCGC GAATTCATGAAGACACTTCCTTTCTGTGCCAC-3=; and LmCA2R, 5=-GCGCGAATTCTTACCGCACAGCCACGGTAC-3=.
CA activity assay. L. major promastigotes (4 ϫ 10 7 cells) were resuspended in 200 l of lysis buffer (25 mM Tris-sulfate [pH 8.2], 150 mM NaH 2 PO 4 , and 1 mM phenylmethylsulfonyl fluoride) and lysed by sonication. As described previously, 50 l of cell lysate was used for measuring CA activity by Maren's endpoint titration method (26) . The average CA activity from 3 different promastigote cultures was expressed in enzyme units (EU)/mg, where 1 unit of enzymatic activity is defined as (T 0 Ϫ T)/T and T and T 0 are, respectively, catalyzed and uncatalyzed times (seconds) required for the drop in pH from 8.5 to 7.0. The total protein concentration in the cell lysate was measured by the method of Lowry et al. (27) . For inhibition studies, the inhibitors (at desired concentrations) were incubated with the L. major cell lysate for 15 min at 4°C prior to the assay. The 50% enzyme activity inhibitory concentrations (IC 50 s) were calculated using OriginPro 8 software. For CA activity assay and inhibition studies in mammalian cells (J774A.1 and NIH 3T3), a similar assay protocol was followed.
Treatment of cells with maneb, zineb, and propineb. The metal dithiocarbamate complexes maneb (manganese ethylene-bis-dithiocarbamate), zineb (zinc ethylene-bis-dithiocarbamate), and propineb (zinc propylene-bis-dithiocarbamate) (structures in Fig. 1 ) were freshly dissolved in dimethyl sulfoxide (DMSO) to prepare 5 mM stock solutions. According to the experimental requirements, further dilutions were made in DMSO before addition to the culture medium. L. major promastigotes and mammalian cells (J774A.1 or NIH 3T3 cells) were grown in medium containing the metal dithiocarbamates at desired concentrations for 96 h and 72 h, respectively, following which the cells were analyzed. Cells incubated with an equivalent concentration of DMSO (0.2%) always acted as untreated controls.
Analysis of cell growth and viability. Following addition of metal dithiocarbamates, the parasite growth was monitored every 24 h by microscopically counting the cells using a hemocytometer. Cell counting was done up to 96 h when the control cells reached the late-log phase of growth. The viabilities of Leishmania and mammalian cells were quantified by the MTT [3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] (Invitrogen) assay as described by Gantt et al. with minor modifications (28) . Briefly, equal numbers of cells from control and dithiocarbamate-treated samples were incubated with 0.5 mg/ml MTT for 3 h to allow formation of purple formazan. Then the cells were washed with phosphate-buffered saline (PBS) and harvested by centrifugation, and the cell pellet was dissolved in 100 l of 0.04 N HCl in isopropanol. The optical density (OD) of the solution was measured on a microplate reader (SpectraMax M2e; Molecular Devices) at a wavelength of 595 nm. Since the OD of formazan produced by the action of mitochondrial dehydrogenases of metabolically active cells correlates with the number of viable cells, the percentage of viability upon drug treatment was calculated using the formula (OD treated /OD control ϫ 100). The 50% lethal doses (LD 50 s) for the parasite populations were calculated using OriginPro 8 software.
Morphological analysis of Leishmania. Untreated and drug-treated L. major promastigotes were washed in PBS, fixed with 2.5% glutaraldehyde, postfixed with 1% OsO 4 , and then dehydrated with increasing concentrations of ethanol (30 to 100%). After dehydration, the cells were placed on silicon wafers for overnight desiccation, coated with gold-palladium, and finally analyzed in a Zeiss Supra 55VP scanning electron microscope (SEM) with accelerating voltage of 5 kV. The lengths of the control and dithiocarbamate-treated L. major cells were measured using MacBiophotonics ImageJ software. At least 40 cells were analyzed for each experimental condition.
Intracellular pH measurement. The intracellular pH (pH i ) of L. major promastigotes was measured using the fluorescent probe, BCECF-AM [2=,7=-bis-(2-carboxyethyl)-5-(and 6)-carboxyfluorescein, acetoxymethyl ester] (Invitrogen) as described earlier (29) . Briefly, L. major promastigotes (1 ϫ 10 7 cells) were washed in PBS and resuspended in 500 l of buffer A (136 mM NaCl, 2.68 mM KCl, 0.8 mM MgSO 4 to that excited at 440 nm (isosbestic point) was recorded in a microplate reader (SpectraMax M2e). The emission wavelength was 535 nm for both cases. The fluorescence ratios were converted into respective pH values with the help of an ionophore-based calibration technique (30) . For generation of the calibration curve, the BCECF fluorescence intensity ratio was recorded as a function of pH by incubating the BCECF-loaded parasites in potassium phosphate buffer of various pH values (pH 5 to 8) containing 5 g/ml of the ionophore nigericin (Invitrogen).
Annexin V and propidium iodide staining. Double staining of L. major promastigotes with annexin V and propidium iodide (PI) was performed using an Alexa Fluor 488 annexin V/dead cell apoptosis kit (Molecular Probes). Briefly, untreated and drug-treated L. major cells (2 ϫ 10 6 ) were harvested, washed twice in ice-cold PBS and resuspended in 200 l of binding buffer containing 5 l of Alexa Fluor 488-annexin V conjugate. The suspension was incubated at room temperature for 30 min in the dark, following which the cells were washed twice with the binding buffer to remove unbound dyes. The cells were then resuspended in PBS containing 1 g/ml PI and incubated for 10 min in the dark. Finally, the cells were washed in PBS and mounted on poly L-lysine-coated slides, which were then embedded in antiquencher solution (1,4- 
The fluorescent images were acquired with an Olympus IX81 epifluorescence microscope. The percentages of annexin V-and PIstained cells were quantified with respect to the total number of DAPIpositive cells in a field. All experiments were done in triplicate, and for each condition, at least 200 cells were analyzed.
Quantitation of intracellular parasite burden. J774A.1 macrophages were activated with 100 ng/ml lipopolysaccharide for 6 h. L. major promastigotes were added to the activated macrophages at a ratio of 30:1 (parasite/macrophage), and the cells were kept for another 6 h. The nonphagocytosed parasites were washed with PBS, and the infected macrophages were incubated for 18 h in the absence or presence of different concentrations of dithiocarbamates. The cells were then fixed with acetone-methanol (1:1) and embedded in antiquencher solution (DABCO) containing DAPI, and the parasite load (number of amastigotes per 100 macrophages) was quantified by imaging the DAPI-stained cells in an Olympus IX81 epifluorescence microscope. All experiments were done in triplicate, and for each condition, at least 100 macrophages (and the corresponding number of amastigotes) were analyzed to quantitate the parasite load.
Statistical analysis. All statistical analyses were done by Student's paired t test, and the results are expressed as the means Ϯ standard deviations (SD). P values of Ͻ0.05 were considered statistically significant.
RESULTS
L. major promastigotes express functional CA that can be inhibited by metal dithiocarbamates. The analysis of the genome database of L. major, the causative agent of cutaneous leishmaniasis, suggested that it encodes two putative CAs (LmCA1 and LmCA2). RT-PCR using gene-specific primers showed constitutive expression of both transcripts in L. major promastigotes (Fig. 2A) . The CA activity in the Leishmania whole-cell lysate was found to be 1.1 EU/mg, confirming the presence of at least one functional CA in Leishmania. This activity was inhibited by all 3 metal dithiocarbamates (i.e., maneb, zineb, and propineb) in a dose-dependent manner with IC 50 s of 0.32 M, 0.28 M, and 0.14 M, respectively (Fig. 2B) .
Stunted growth and abnormal morphology of the metal dithiocarbamate-treated parasites. To study the effects of these metal dithiocarbamates on L. major promastigotes, the parasites were grown in the absence or presence of increasing concentrations of maneb, zineb, or propineb, and the total numbers of cells were counted after 96 h of growth. Data presented in Fig. 3A clearly show that submicromolar concentrations of all three metal dithiocarbamates inhibited the parasite growth to a significant extent. The treated L. major promastigotes exhibited rounded morphology with membrane blebs as revealed by SEM images (Fig. 3B) . The average lengths of the maneb-, zineb-, and propineb-treated parasites were 6.3 m, 5 m, and 6.8 m, respectively, compared to 11.7 m for the untreated cells, indicating that the metal dithiocarbamate-treated Leishmania cells were under stress (Fig. 3C) .
Cytotoxicity of metal dithiocarbamates on Leishmania cells. The viability of metal dithiocarbamate-treated L. major promastigotes was analyzed by MTT assay. We found that treatment with all 3 metal dithiocarbamates resulted in a concentration-dependent reduction in the viability of Leishmania cells, with LD 50 val- ues of 0.56 M, 0.61 M, and 0.27 M for maneb, zineb, and propineb, respectively (Fig. 4A) . Since Leishmania parasites reside within acidic phagolysosomes of the infected host cells, we tested the effect of these compounds on parasites growing in acidic medium (pH 5.5). In this acidic environment, the parasites exhibited markedly increased susceptibility to the metal dithiocarbamates as reflected by their severalfold-lower LD 50 values: 0.048 M, 0.049 M, and 0.041 M for maneb, zineb, and propineb, respectively (Fig. 4B) . This result suggests that these metal dithiocarbamates would effectively kill the parasites residing inside the acidic phagolysosomal compartment of host cells. It was encouraging to find that maneb, zineb, and propineb were also effective against Leishmania donovani, the causative agent of visceral leishmaniasis, in which they caused dose-dependent growth inhibition as well as cytotoxicity (see Fig. S1 in the supplemental material).
Intracellular acidosis of Leishmania cells upon treatment with metal dithiocarbamates. Since in higher organisms, CA activity is known to be important for intracellular pH maintenance, we next tested whether metal dithiocarbamate-mediated inhibition of LmCAs resulted in intracellular acidosis of Leishmania parasites (31) . For this, L. major promastigotes were grown in the absence or presence of maneb, zineb, or propineb, and the intracellular pH (pH i ) of the cells was measured by loading them with the fluorescent pH indicator BCECF-AM. The steady-state pH i of the untreated cells was found to be almost neutral (i.e., 6.93), whereas the pH i values of the metal dithiocarbamate-treated cells were ϳ0.2 unit lower in each case, i.e., 6.68, 6.72, and 6.71, respectively, for the maneb-, zineb-, and propineb-treated parasites (Table 1). The extent of intracellular acidification upon metal dithiocarbamate treatment was more pronounced when the parasites were grown in acidic medium (pH 5.5). At this acidic external pH, the difference in pH i between the untreated and metal dithiocarbamate-treated L. major cells was ϳ0.3 pH unit. The untreated cells maintained a pH i of 6.81, whereas the cells treated with maneb, zineb, and propineb had significantly lower pH i s of 6.46, 6.53, and 6.49, respectively (Table 1) . These findings demonstrated that metal dithiocarbamate treatment caused intracellular acidosis which may be responsible, at least in part, for Leishmania cell death.
Apoptotic and necrotic cell death of metal dithiocarbamatetreated parasites. The mechanism of Leishmania cell death upon treatment with metal dithiocarbamates was analyzed by annexin V and PI double staining. Annexin V specifically binds to the phosphatidylserine exposed on the outer leaflet of the apoptotic cell membrane, whereas PI is a membrane-impermeant fluorescent dye that interacts with the DNA and RNA of those cells whose membrane integrity is lost (e.g., in late apoptotic or necrotic cells) (32) . Data presented in Fig. 5A show that, compared to the untreated cells, there was a significant increase in the number of late apoptotic (annexin V-positive/PI-positive [annexin V ϩ /PI ϩ ]) and necrotic (annexin V-negative [annexin V Ϫ ]/PI ϩ ]) cells upon treatment with 0.625 M maneb, zineb, or propineb. Analysis of several such images revealed that the percentages of late apoptotic and necrotic cells were 2% and 3% for untreated cells, 21% and 33% for maneb-treated cells, 19% and 38% for zineb-treated cells, and 26% and 48% for propineb-treated cells, respectively. The numbers of early apoptotic cells (annexin V ϩ /PI Ϫ ) were negligible in all the cases, suggesting that a major proportion of the metal dithiocarbamate-treated cells were at advanced stages of cell death (Fig. 5B) .
Reduced intracellular parasite burden upon treatment with metal dithiocarbamates. Having confirmed the antileishmanial properties of the metal dithiocarbamates in vitro, we wanted to determine the effect of these compounds on parasites residing inside the host macrophages. For this, J774A.1 macrophages were infected with L. major promastigotes, and the infected cells were incubated in the absence or presence of maneb, zineb, or propineb. Data presented in Fig. 6 show that all 3 metal dithiocarbamates caused a dose-dependent reduction in the number of intracellular amastigotes. Treatment with 0.625 M zineb or propineb resulted in Ͼ50% reduction in the parasite load (number of amastigotes/100 macrophages), whereas for maneb-treated cells the drop in the intracellular parasite load was 43%.
Metal dithiocarbamates are fairly nontoxic to mammalian cells. MTT assay was employed to test the cytotoxicity of maneb, zineb, and propineb on two mammalian cell lines, J774A.1 (macrophage) and NIH 3T3 (fibroblast). The cells were treated with various concentrations of the metal dithiocarbamates up to a maximum concentration of 5 M. We found that none of these compounds exhibited any cytotoxic effect on mammalian cells even at a 5 M concentration (Fig. 7A) . Taken together, our data suggest that these metal dithiocarbamates are fairly nontoxic for mammalian cells and are highly selective in targeting the Leishmania cells. The fact that the CA activity in J774A.1 and NIH 3T3 cells was not inhibited even in the presence of 5 M maneb, zineb, or propineb is plausibly the reason for this selective cytotoxicity (Fig. 7B) .
DISCUSSION
Variable efficacy and development of resistance against existing drugs pose serious challenges in controlling leishmaniasis in different parts of the world (5-7). A steady pipeline of novel therapies is therefore critical for our continued effort to combat this complex disease. As a significant step toward this, the potent antileishmanial properties of maneb, zineb, and propineb reported here promise to strengthen the chemotherapeutic repertoire against leishmaniasis. Interestingly, mammalian cells were not affected by these metal dithiocarbamates even at a concentration which is severalfold higher than their antileishmanial LD 50 s. The efficacy and broad therapeutic indices of this new class of antileishmanial compounds are thus very striking and warrant further preclinical studies for drug development.
Dithiocarbamates and their metal complexes have been used as antifungal agents in agriculture for decades without much knowledge about their mode of action (33) . A mechanistic insight into their fungicidal property was provided only recently when a wide range of dithiocarbamates were found to be strong inhibitors of ␤-CAs from three fungal pathogens, C. neoformans, Candida albicans, and Candida glabrata (25) . In subsequent reports, ␤-CAs from M. tuberculosis, ␣-CA from T. cruzi, and the physiologically important human ␣-CAs, e.g., CAI, -II, -IX, and -XII, were also shown to be inhibited by submicromolar concentrations of dithiocarbamates, thereby establishing them as a general class of CA inhibitors (22, 23, 34, 35) .
The notion that metal dithiocarbamates may have antileishmanial activity originated from our experiment in which maneb, zineb, and propineb were found to be strong inhibitors of CA activity in L. major promastigotes. Given that CAs play important physiological roles in a variety of organisms, it was necessary to test whether dithiocarbamate-mediated CA inhibition is detrimental for the parasite growth and/or survival (9) . Indeed, 3 metal dithiocarbamate complexes chosen for this study all caused significant growth inhibition and morphological abnormalities of L. major promastigotes. These compounds were also highly cytotoxic for the parasite as evident from the MTT assay. The submicromolar LD 50 values of these metal dithiocarbamates (0.56 M for maneb, 0.61 M for zineb, and 0.27 M for propineb) indicate that their in vitro leishmanicidal activity is comparable to that of amphotericin B, which is thus far the most potent antileishmanial drug (36) . The heterocyclic thiols are the only known CA inhibitors reported to exhibit antileishmanial activity. However, they are effective against L. chagasi and L. amazonensis at a much higher concentration (MIC of Ͼ250 M) and hence appear to be less potent than maneb, zineb, or propineb (19) .
These metal dithiocarbamates were even more effective against parasites growing in acidic medium (pH 5.5 as opposed to pH 7.2) for which their LD 50 values were severalfold lower (0.048 M for maneb, 0.049 M for zineb, and 0.041 M for propineb). This result prompted us to ask whether treatment with metal dithiocarbamates, which are potent CA inhibitors, led to intracellular acidification of Leishmania cells. This was a relevant question because CAs, by accelerating the rate of CO 2 /HCO 3 Ϫ buffering in the cytosol, are known to play important roles in intracellular pH maintenance (31) . This function of CAs is even more critical for actively metabolizing tumor cells, where the interplay between cytosolic CAII and membrane-bound CAIX helps in regulating intracellular pH (37) . Our results confirmed that indeed the pH i of metal dithiocarbamate-treated L. major promastigotes was ϳ0.2 unit lower than that of the untreated cells (pH i ϭ 6.93). For Leishmania cells growing in acidic media (pH 5.5), the pH i dropped by almost 0.3 unit upon treatment with maneb, zineb, or propineb, suggesting that the intracellular buffering system of Leishmania is the target of these metal dithiocarbamates. However, it is also possible that other CA-dependent metabolic processes like fatty acid biosynthesis and gluconeogenesis are inhibited by these metal dithiocarbamates (9) . Furthermore, the off-target effects of these compounds cannot be completely ruled out, and it is to be noted that pyrrolidine dithiocarbamate at concentrations of 10 M and above was shown to inhibit proteasomal activity and NF-B (38, 39) .
The mechanism of Leishmania cell death was next investigated. Annexin V/PI staining confirmed that apoptosis and necrosis are the causes of metal dithiocarbamate-mediated killing of L. major promastigotes. The Leishmania cell death is plausibly a consequence of intracellular acidosis, as was observed earlier in different cell types like neuronal cells, tumor cells, and phagocytic cells, in which deregulation of intracellular pH acted as a trigger for apoptosis and/or necrosis (40) (41) (42) . Several studies suggested that cell death induced by intracellular acidosis can also be exploited for therapeutic purposes. For example, lowering of pH i by pharmacological inhibition of CAIX has been shown to activate ceramidemediated apoptosis in human cancer cells (43) . This finding was corroborated by in vivo experiments where CAIX gene silencing led to a 40% reduction in xenograft tumor volume in mice (44) . H. pylori, when treated with acetazolamide under acidic conditions, lost its cytoplasmic/periplasmic buffering capacity with a simultaneous decrease in its ability to survive in low pH (45) . This observation might explain how gastric ulcer patients were successfully treated with CA inhibitors with Ͼ90% healing efficiency (46) . The potential clinical benefits of this pH i modulatory property of CA inhibitors are quite appealing and further highlight the possible therapeutic application of these metal dithiocarbamates.
Can these metal dithiocarbamates be used as antileishmanial drugs? The reduced parasite burdens of metal dithiocarbamatetreated macrophages suggest that in addition to their in vitro antileishmanial activity, these compounds also have the potential to target intracellular amastigotes and hence can be considered lead compounds for antileishmanial drug development. The toxicity of these metal dithiocarbamates and their cellular metabolites (carbon disulfide and ethylene/propylene thiourea) might be a matter of concern (47) . But it is to be noted that maneb, zineb, and propineb are reported to be cytotoxic for mammalian cells only at a concentration which is at least 50 times higher than their antileishmanial LD 50 s (48, 49) . Similarly, the neuropathic effects of carbon disulfide-or ethylene thiourea-induced thyroid tumors were observed in rats after chronic exposure to a very high dose of these compounds (e.g., when exposed to 700 ppm or 9.19 mM carbon disulfide for 2 h/day, 5 days/week for 12 weeks or fed with Ͼ250 ppm or 2.44 mM ethylene thiourea in the diet for 2 years) (50, 51) . So, the submicromolar doses at which these metal dithiocarbamates are effective against the parasites should be safe for the mammalian cells. Our results also confirmed that maneb, zineb, or propineb, up to a concentration of 5 M, did not have any cytotoxic effects on 2 mammalian cell lines, i.e., J774A.1 (macrophage) and NIH 3T3 (fibroblast). From our data, it appears that L. major-infected J774A.1 macrophages were incubated for 18 h in the absence (0 M, gray bar) or in the presence of 0.312 M or 0.625 M maneb (black bars), zineb (dotted bars), or propineb (white bars), following which the cells were fixed and stained with DAPI. Based on the total number of DAPI-stained nuclei of macrophages and amastigotes in a field, the number of intracellular amastigotes/100 macrophages (parasite load) was calculated from the images captured in an epifluorescence microscope. For each condition, at least 100 macrophages (and the corresponding number of amastigotes) were analyzed. Error bars represent the means Ϯ SD of values from triplicate experiments. *, Significant difference (P Ͻ 0.05) with respect to the untreated control. .1 (black bars) and NIH 3T3 (white bars) whole-cell lysates were incubated for 15 min in the absence (no inhibitor) or presence of 5 M maneb, zineb, or propineb, following which the CA specific activities (EU/mg) were measured. Data represent the relative specific activities, i.e., the specific activity in the presence of inhibitor/specific activity in the absence of inhibitor. The error bars in both experiments represent the means Ϯ SD of values from 3 independent experiments. these metal dithiocarbamates are more superior inhibitors for LmCAs than their mammalian counterparts, which might be the basis for their differential cytotoxicity. The encapsulation of these compounds within liposomes or biocompatible nanocarriers might be a way to further reduce their toxic effects and improve their bioavailability as well as macrophage targeting.
In conclusion, potent antileishmanial activity coupled with broad therapeutic indices of maneb, zineb, and propineb is very promising and provides an important lead toward the development of a new class of safe and effective antileishmanial drugs. It will be tempting to evaluate the efficacy of these metal dithiocarbamates against the drug-resistant strains of Leishmania.
